Arcturus Therapeutics
ARCT
#8392
Rank
โ‚น22.64 B
Marketcap
โ‚น796.57
Share price
-5.30%
Change (1 day)
-26.49%
Change (1 year)

Earnings for Arcturus Therapeutics (ARCT)

Earnings in 2025 (TTM): -โ‚น6.48 Billion

According to Arcturus Therapeutics 's latest financial reports the company's current earnings are โ‚น85.14 Million. In 2024 the company made an earning of -โ‚น8.76 Billion a decrease over its 2023 earnings that were of -โ‚น2.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arcturus Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น6.48 Billion-26.01%
2024 -โ‚น8.76 Billion240.24%
2023 -โ‚น2.58 Billion-298.78%
2022 โ‚น1.29 B-106.79%
2021 -โ‚น19.07 Billion181.83%
2020 -โ‚น6.77 Billion183.72%
2019 -โ‚น2.39 Billion16.93%
2018 -โ‚น2.04 Billion154.5%
2017 -โ‚น0.81 Billion-65.36%
2016 -โ‚น2.32 Billion25.93%
2015 -โ‚น1.84 Billion-41.04%
2014 -โ‚น3.12 Billion219.64%
2013 -โ‚น0.98 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚น0.21 Billion-97.12% Bahamas
NRC Health
NRC
โ‚น2.61 B-136.78%๐Ÿ‡บ๐Ÿ‡ธ USA